Spicer J, Blais N, Owen S, Robinson AG, et al. A Phase II Study of Neoadjuvant Opnurasib KRAS G12C Inhibitor in Patients With Surgically Resectable Non-Small Cell Lung Cancer (CCTG IND.242A): A Substudy of the IND.242 Platform Master Protocol. Clin Lung Cancer 2024 Sep 20:S1525-7304(24)00198.
PMID: 39394034